|
| |||||||
| Timeline | 0 h | 1 h | 3 h | 3.5 h | 4 h | ||
|
|
|
| Baseline | Trial medicine treatment | Supine BP during renography | After renography | Changes between baseline and supine BP |
| Systolic (mmHg) | bBP | - tolvaptan | 137 ± 12 | 138 ± 12 | 135 ± 13* | 140 ± 16 | 2 ± 10 |
| - placebo | 138 ± 18 | 141 ± 16 | 141 ± 18 | 144 ± 21 | −3 ± 15 | ||
| cBP | - tolvaptan | 126 ± 11 | 127 ± 9 | 125 ± 13 | 131 ± 14 | 2 ± 11 | |
| - placebo | 128 ± 16 | 130 ± 15 | 131 ± 19 | 134 ± 21 | −3 ± 15 | ||
| Diastolic (mmHg) | bBP | - tolvaptan | 92 ± 9 | 94 ± 9 | 87 ± 10 | 96 ± 11 | 5 ± 6 |
| - placebo | 92 ± 10 | 95 ± 12 | 89 ± 14 | 96 ± 16 | 4 ± 8 | ||
| cBP | - tolvaptan | 93 ± 9 | 95 ± 9 | 88 ± 10 | 98 ± 11 | 5 ± 7 | |
| - placebo | 93 ± 10 | 97 ± 12 | 90 ± 13 | 98 ± 15 | 5 ± 8 | ||